{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:41:54Z","timestamp":1788871314845,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007416","name":"Japan Health Sciences Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.cyto.2008.07.003","type":"journal-article","created":{"date-parts":[[2008,9,24]],"date-time":"2008-09-24T05:29:23Z","timestamp":1222234163000},"page":"229-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["The therapeutic effect of TNFR1-selective antagonistic mutant TNF-\u03b1 in murine hepatitis models"],"prefix":"10.1016","volume":"44","author":[{"given":"Hiroko","family":"Shibata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Ohkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Taniai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunetaka","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadanori","family":"Mayumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2008.07.003_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0167-4889(02)00326-9","article-title":"The role of cytokines in liver failure and regeneration: potential new molecular therapies","volume":"1592","author":"Galun","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cyto.2008.07.003_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11894-003-0008-8","article-title":"Etiology and management of fulminant hepatic failure","volume":"5","author":"Vaquero","year":"2003","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cyto.2008.07.003_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2003-42641","article-title":"Acute liver failure in the United States","volume":"23","author":"Lee","year":"2003","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cyto.2008.07.003_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.med.45.1.491","article-title":"Tumor necrosis factor: a pleiotropic cytokine and therapeutic target","volume":"45","author":"Tracey","year":"1994","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.cyto.2008.07.003_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2008.07.003_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(88)90006-2","article-title":"Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure","volume":"2","author":"Muto","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2008.07.003_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-112-12-917","article-title":"Increased plasma tumor necrosis factor in severe alcoholic hepatitis","volume":"112","author":"Bird","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cyto.2008.07.003_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.179.3.841","article-title":"Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis","volume":"179","author":"Gonzalez-Amaro","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2008.07.003_bib9","first-page":"G387","article-title":"Mechanisms of hepatic toxicity. I. TNF-induced liver injury","volume":"275","author":"Bradham","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cyto.2008.07.003_bib10","doi-asserted-by":"crossref","first-page":"G497","DOI":"10.1152\/ajpgi.00171.2004","article-title":"Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease","volume":"287","author":"McClain","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cyto.2008.07.003_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cyto.2008.07.003_bib12","doi-asserted-by":"crossref","unstructured":"Carroll MB, Bond MI. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection. Semin Arthritis Rheum 2008, in press.","DOI":"10.1016\/j.semarthrit.2007.10.011"},{"key":"10.1016\/j.cyto.2008.07.003_bib13","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2008.07.003_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(02)07714-0","article-title":"Drug-induced systemic lupus erythematosus associated with etanercept therapy","volume":"359","author":"Shakoor","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2008.07.003_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/318665a0","article-title":"Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon","volume":"318","author":"Aggarwal","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2008.07.003_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.cyto.2008.07.003_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0898-6568(01)00262-5","article-title":"TNF receptor subtype signalling: differences and cellular consequences","volume":"14","author":"MacEwan","year":"2002","journal-title":"Cell Signal"},{"key":"10.1016\/j.cyto.2008.07.003_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.cyto.2008.07.003_bib19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nbt812","article-title":"Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity","volume":"21","author":"Yamamoto","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cyto.2008.07.003_bib20","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1158\/1078-0432.CCR-04-0770","article-title":"Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window","volume":"10","author":"Shibata","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cyto.2008.07.003_bib21","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1074\/jbc.M707933200","article-title":"Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist","volume":"283","author":"Shibata","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2008.07.003_bib22","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.4049\/jimmunol.154.6.2904","article-title":"Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells","volume":"154","author":"Vandenabeele","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2008.07.003_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0163-7258(89)90050-8","article-title":"Mechanisms of carbon tetrachloride toxicity","volume":"43","author":"Recknagel","year":"1989","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cyto.2008.07.003_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2008.07.003_bib25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1084\/jem.179.5.1529","article-title":"T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6","volume":"179","author":"Mizuhara","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2008.07.003_bib26","doi-asserted-by":"crossref","first-page":"13622","DOI":"10.1073\/pnas.0501758102","article-title":"The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation","volume":"102","author":"Wolf","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2008.07.003_bib27","first-page":"133","article-title":"Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity","volume":"25","author":"Bruccoleri","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2008.07.003_bib28","first-page":"1577","article-title":"Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor","volume":"152","author":"Yamada","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2008.07.003_bib29","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/gast.2001.22441","article-title":"The lymphoid liver: considerations on pathways to autoimmune injury","volume":"120","author":"Kita","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2008.07.003_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/jhep.2002.30991","article-title":"Current and novel immunosuppressive therapy for autoimmune hepatitis","volume":"35","author":"Heneghan","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2008.07.003_bib31","first-page":"1416","article-title":"Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis","volume":"24","author":"Lohr","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2008.07.003_bib32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/364798a0","article-title":"Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes","volume":"364","author":"Rothe","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2008.07.003_bib33","doi-asserted-by":"crossref","first-page":"R1202","DOI":"10.1152\/ajpregu.2000.278.5.R1202","article-title":"LPS-induced liver injury in d-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor","volume":"278","author":"Nowak","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.cyto.2008.07.003_bib34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","article-title":"The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80kDa tumor necrosis factor receptor","volume":"83","author":"Grell","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2008.07.003_bib35","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/eji.1830271119","article-title":"In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis","volume":"27","author":"Kusters","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2008.07.003_bib36","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1002\/eji.1830271018","article-title":"A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55\/p75 TNF receptor signaling","volume":"27","author":"Alexopoulou","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2008.07.003_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1570161043385682","article-title":"Recent progress on tumor missile therapy and tumor vascular targeting therapy as a new approach","volume":"2","author":"Yoshioka","year":"2004","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.cyto.2008.07.003_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1386207053258578","article-title":"Phage display and PEGylation of therapeutic proteins","volume":"8","author":"Mukai","year":"2005","journal-title":"Comb Chem High Throughput Screen"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466608001993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466608001993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:48:19Z","timestamp":1760906899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466608001993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S1043466608001993"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2008.07.003","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic effect of TNFR1-selective antagonistic mutant TNF-\u03b1 in murine hepatitis models","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2008.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}